DK156001C - Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner - Google Patents

Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner

Info

Publication number
DK156001C
DK156001C DK278379A DK278379A DK156001C DK 156001 C DK156001 C DK 156001C DK 278379 A DK278379 A DK 278379A DK 278379 A DK278379 A DK 278379A DK 156001 C DK156001 C DK 156001C
Authority
DK
Denmark
Prior art keywords
benzazepines
mercaptos
tetrahydro
analogue
substituted
Prior art date
Application number
DK278379A
Other languages
English (en)
Other versions
DK278379A (da
DK156001B (da
Inventor
Kenneth George Holden
Carl Kaiser
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of DK278379A publication Critical patent/DK278379A/da
Publication of DK156001B publication Critical patent/DK156001B/da
Application granted granted Critical
Publication of DK156001C publication Critical patent/DK156001C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK278379A 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner DK156001C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92261378A 1978-07-07 1978-07-07
US92261378 1978-07-07

Publications (3)

Publication Number Publication Date
DK278379A DK278379A (da) 1980-01-08
DK156001B DK156001B (da) 1989-06-12
DK156001C true DK156001C (da) 1989-11-06

Family

ID=25447325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278379A DK156001C (da) 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner

Country Status (24)

Country Link
EP (2) EP0080012B1 (da)
JP (1) JPS5511584A (da)
AR (1) AR222828A1 (da)
AU (1) AU525789B2 (da)
CA (1) CA1115271A (da)
CS (1) CS213381B2 (da)
DD (1) DD147355A5 (da)
DE (1) DE2964530D1 (da)
DK (1) DK156001C (da)
ES (3) ES482282A1 (da)
FI (1) FI67215C (da)
GR (1) GR69675B (da)
HU (1) HU179315B (da)
IE (1) IE48654B1 (da)
IL (1) IL57532A (da)
IT (1) IT1193190B (da)
JO (1) JO1273B1 (da)
NO (1) NO152213C (da)
NZ (1) NZ190745A (da)
PH (1) PH15754A (da)
PL (1) PL216908A1 (da)
PT (1) PT69855A (da)
SU (1) SU1029827A3 (da)
ZA (1) ZA792785B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4652642A (en) * 1984-08-23 1987-03-24 Smithkline Beckman Corporation Azidobenzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
IL142388A0 (en) * 1998-10-08 2002-03-10 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
DE60305519T2 (de) 2002-10-07 2006-11-23 Glaxo Group Ltd., Greenford Sulfonamidderivate als antipsychotische mittel
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EA011011B1 (ru) * 2004-02-25 2008-12-30 Эли Лилли Энд Компани 6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT
CA2589988C (en) 2004-12-21 2017-02-14 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
CN103347523A (zh) 2010-09-01 2013-10-09 艾尼纳制药公司 向具有肾损伤的个体给药氯卡色林
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management
CN116655892A (zh) * 2023-05-18 2023-08-29 常州大学 一种交联聚合物有机电极材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520264A (en) * 1947-08-26 1950-08-29 Maltbie Lab Inc Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
GB1268243A (en) * 1968-03-11 1972-03-22 Wallace & Tiernan Inc 0,2,4,5,-tetrahydro-3h,3-benzazepines
US3671519A (en) * 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3716639A (en) 1970-03-11 1973-02-13 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepines
US3752892A (en) 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4108989A (en) * 1977-04-01 1978-08-22 Smithkline Corporation 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones

Also Published As

Publication number Publication date
DK278379A (da) 1980-01-08
PH15754A (en) 1983-03-18
IT7924165A0 (it) 1979-07-06
DD147355A5 (de) 1981-04-01
IE791276L (en) 1980-01-07
NO792267L (no) 1980-01-08
GR69675B (da) 1982-07-07
ZA792785B (en) 1980-08-27
JPS5511584A (en) 1980-01-26
PT69855A (en) 1979-08-01
AU525789B2 (en) 1982-12-02
ES482281A1 (es) 1980-04-01
IL57532A (en) 1982-08-31
JPH0153271B2 (da) 1989-11-13
IT1193190B (it) 1988-06-02
AR222828A1 (es) 1981-06-30
JO1273B1 (en) 1986-11-30
NO152213C (no) 1985-08-28
NO152213B (no) 1985-05-13
EP0080012B1 (en) 1986-04-09
FI67215C (fi) 1985-02-11
HU179315B (en) 1982-09-28
IL57532A0 (en) 1979-10-31
SU1029827A3 (ru) 1983-07-15
PL216908A1 (da) 1980-08-11
NZ190745A (en) 1981-01-23
EP0007070A1 (en) 1980-01-23
FI67215B (fi) 1984-10-31
CS213381B2 (en) 1982-04-09
EP0007070B1 (en) 1983-01-19
DE2964530D1 (en) 1983-02-24
DK156001B (da) 1989-06-12
AU4861379A (en) 1980-02-07
FI792125A7 (fi) 1980-01-08
EP0080012A1 (en) 1983-06-01
CA1115271A (en) 1981-12-29
IE48654B1 (en) 1985-04-03
ES482276A1 (es) 1980-04-01
ES482282A1 (es) 1980-04-01

Similar Documents

Publication Publication Date Title
DK156001C (da) Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner
DK281079A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-2-nitroimidazoler
DK155048C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser
DK162601C (da) Analogifremgangsmaade til fremstilling af 8-oe4-oe4-(2,1-benzisothiazol-3-yl)-1-piperazinylaabutylaa-8-azaspirooe4.5aadecan-7,9-dion
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK150068C (da) Analogifremgangsmaade til fremstilling af aminothiazoler
DK149846C (da) Analogifremgangsmaade til fremstilling af n,n'-bis-tetrahydro-isoquinolyldisulfonylimider
DK147178C (da) Fremgangsmaade til 1-hydroxylering af 5,6-trans-vitamin d-forbindelser
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK504979A (da) Fremgangsmaade til fremstilling af 1,2,4,5-tetraalkyl-4-arylpiperidiner
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK444479A (da) Fremgangsmaade til fremstilling af 3,4-dihydro-3-oxo-2-quinoxaliner
DK260579A (da) Fremgangsmaade til fremstilling af 14,15-methylenderivater af oestranraekken
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK459579A (da) Fremgangsmaade til fremstilling af 1,2,3-thiadiazol-5-ylurinstoffer
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
FI793444A7 (fi) Menetelmä uusien aryylitrifluorietanolien valmistamiseksi.
FI793221A7 (fi) Menetelmä substituoitujen pyrrolidiestereiden valmistamiseksi.
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
FI792449A7 (fi) Menetelmä uusien tiosubstituoitujen diatsasykloalkeenien valmistamiseksi.
DK239279A (da) Fremgangsmaade til fremstilling af 2-oximinophenylacetonitril

Legal Events

Date Code Title Description
PBP Patent lapsed